Cargando…
Tim-3 expression and its role in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common tumors in the world, and its mortality is still on the rise. Limited treatments and low chemotherapy sensitivity of HCC make new therapeutic strategies urgently needed. With the rise of immune checkpoint blockade, anti-CTLA-4 antibodies and an...
Autores principales: | Liu, Feifei, Liu, Yanning, Chen, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182863/ https://www.ncbi.nlm.nih.gov/pubmed/30309387 http://dx.doi.org/10.1186/s13045-018-0667-4 |
Ejemplares similares
-
The Role of TIM-3 in Hepatocellular Carcinoma: A Promising Target for Immunotherapy?
por: Ganjalikhani Hakemi, Mazdak, et al.
Publicado: (2020) -
TIM-3 expression and its association with overall survival in primary osteosarcoma
por: Pu, Feifei, et al.
Publicado: (2019) -
Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022) -
An Emerging Role of TIM3 Expression on T Cells in Chronic Kidney Inflammation
por: Lu, Can, et al.
Publicado: (2022) -
Immune regulation by Tim-3
por: Banerjee, Hridesh, et al.
Publicado: (2018)